Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Total 13F shares
-
37,428,616
-
Share change
-
+447,622
-
Total reported value
-
$183,549,240
-
Put/Call ratio
-
69%
-
Price per share
-
$4.90
-
Number of holders
-
84
-
Value change
-
+$443,920
-
Number of buys
-
37
-
Number of sells
-
39
Institutional Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q3 2021
As of 30 Sep 2021 Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) had 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,428,616 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., PRIMECAP MANAGEMENT CO/CA/, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MAVERICK CAPITAL LTD, BlackRock Inc., Bellevue Group AG, D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, JPMORGAN CHASE & CO, and Artal Group S.A..
This table shows 84 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.